[HTML][HTML] Pathomechanism and management of stroke in COVID-19: review of immunopathogenesis, coagulopathy, endothelial dysfunction, and downregulation of …
PL Rahmawati, K Tini, NM Susilawathi… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke,
with most cases presenting as large vessel ischemic stroke in patients with or without …
with most cases presenting as large vessel ischemic stroke in patients with or without …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL Rahmawati, K Tini, NM Susilawathi… - Journal of Clinical …, 2021 - dbpia.co.kr
Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
[PDF][PDF] Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of …
PL Rahmawatia, K Tinib, NM Susilawathib… - J Clin …, 2021 - scienceopen.com
Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL Rahmawati, K Tini… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL Rahmawati, K Tini, NM Susilawathi… - Journal of Clinical …, 2021 - oldkmbase.medric.or.kr
Abstract Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke,
with most cases presenting as large vessel ischemic stroke in patients with or without …
with most cases presenting as large vessel ischemic stroke in patients with or without …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL Rahmawati, K Tini, NM Susilawathi, IA Wijayanti… - Journal of Clinical … - KoreaMed
Abstract Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke,
with most cases presenting as large vessel ischemic stroke in patients with or without …
with most cases presenting as large vessel ischemic stroke in patients with or without …
[PDF][PDF] Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of …
PL Rahmawatia, K Tinib, NM Susilawathib… - J Clin …, 2021 - academia.edu
Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL RAHMAWATI, K TINI… - Journal of Clinical …, 2021 - pesquisa.bvsalud.org
ABSTRACT Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute
stroke, with most cases presenting as large vessel ischemic stroke in patients with or without …
stroke, with most cases presenting as large vessel ischemic stroke in patients with or without …
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
PL Rahmawati, K Tini, NM Susilawathi… - Journal of Clinical …, 2021 - kiss.kstudy.com
Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
cases presenting as large vessel ischemic stroke in patients with or without comorbidities …
[HTML][HTML] Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of …
PL Rahmawati, K Tini, NM Susilawathi… - Journal of Clinical …, 2021 - thejcn.com
Abstract Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke,
with most cases presenting as large vessel ischemic stroke in patients with or without …
with most cases presenting as large vessel ischemic stroke in patients with or without …